Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

NCT05722522 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped Project discontinued to prioritize other key programs in portfolio

Conditions

Rotator Cuff Tendinopathy

Interventions

DRUG: Secukinumab
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals